Drug
Cobicistat
Cobicistat: highest development phase Approved, developed by Gilead Sciences. 1 trial record tracked on RxWires.
- Highest phase
- Approved
- Developer
- Gilead Sciences
Trials
| Drug | Phase | Indication |
|---|---|---|
| GENVOYA | Approved |
Latest
- GENVOYA: patent 8981103 expired 2026-10-26
- GENVOYA: patent 7635704 expired 2026-10-26
Follow Cobicistat on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.